Wilson Sonsini Goodrich & Rosati advised SR One Capital Management on the deal.ADARx Pharmaceuticals, Inc., a biotechnology company developing RNA targeting therapeutics, announced the completion of…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now